The Latest Breaking News from Moderna

With low implied volatility right now, a bear put spread on Moderna is a viable strategy to profit on the downside.

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

The five best S&P 500 performers Monday included Enphase Energy and First Solar. Moderna was a key laggard. Banks were big winners and losers.

Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a "longish and complex path" toward approval.

Google parent Alphabet sold off more than 3% after Samsung considered ditching the search engine.

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

Moderna stock skidded Tuesday on a mixed update for its mRNA-based flu vaccine. The update could impact the shot's commercial timing.